Skip header and navigation

1 records – page 1 of 1.

A 24-week dietary and physical activity lifestyle intervention reduces hepatic insulin resistance in the obese with chronic hepatitis C.

https://arctichealth.org/en/permalink/ahliterature117638
Source
Liver Int. 2013 Mar;33(3):410-9
Publication Type
Article
Date
Mar-2013
Author
Venessa Pattullo
Andres Duarte-Rojo
Wael Soliman
Florencia Vargas-Vorackova
Sanjeev Sockalingam
Ivan G Fantus
Johane Allard
Jenny Heathcote
Author Affiliation
Department of Medicine, University Health Network, University of Toronto, Toronto, ON, Canada.
Source
Liver Int. 2013 Mar;33(3):410-9
Date
Mar-2013
Language
English
Publication Type
Article
Keywords
Anthropometry
Basal Metabolism
Blood pressure
Body mass index
Exercise Therapy - methods
Female
Hepatitis C, Chronic - complications - pathology
Humans
Insulin Resistance - physiology
Male
Middle Aged
Motor Activity - physiology
Obesity - complications - diet therapy - therapy
Ontario
Prospective Studies
Statistics, nonparametric
Abstract
Obesity- and virus-mediated insulin resistance (IR) are associated with adverse hepatic and metabolic outcomes in chronic hepatitis C (CHC). This study evaluates the tolerability and effects of a dietary and physical activity (PA) intervention in obese patients with insulin-resistant CHC.
Obese patients (body mass index, BMI =30 kg/m(2) ) with CHC were recruited prospectively. Non-diabetic patients with IR (homeostasis model assessment of IR, HOMA-IR >2.0) proceeded to a 24-week lifestyle intervention comprising pedometer monitored increase in PA (=10 000 steps/day) and an individualised dietary plan.
Ten non-cirrhotic and six cirrhotic patients [age 52 ± 8.5 years, BMI 35.9 (31.46-38.21)kg/m(2) ] were recruited, of whom all 16 (100%) completed the 24-week protocol. Increase in PA from 6853 (2440-9533) to 10 697 (7959-13566) steps/day (P = 0.001) and reduction in caloric intake from 2263 (1805.4-2697.0) to 1281 (1099.5-1856.3) kcal/day (equivalent to reduction of median 33% (25.3-49.8%), P
PubMed ID
23278982 View in PubMed
Less detail